Showing results (121-130 of 246) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Investigation|February 25, 2020
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancerHimisha Beltran, Alessandro Romanel, Vincenza Conteduca, et al.
NAR Cancer|June 6, 2022
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assayFrancesco Orlando, Alessandro Romanel, Blanca Trujillo, et al.
Research Square|September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerLeigh Ellis, Beatriz German, Katherine Morel, et al.
Nature Communications|November 26, 2014
ERG induces taxane resistance in castration-resistant prostate cancerGiuseppe Galletti, Alexandre Matov, Himisha Beltran, et al.
Nature|August 31, 2018
Publisher Correction: Suppression of insulin feedback enhances the efficacy of PI3K inhibitorsBenjamin D Hopkins, Chantal Pauli, Xing Du, et al.
Cancer & Metabolism|September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NADJack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
Cancer Cell|April 2, 2019
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate TumorigenesisMichael A Augello, Deli Liu, Lesa D Deonarine, et al.
The Journal of Clinical Investigation|July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancerAdeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Nature Communications|June 8, 2021
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancerNicholas J Brady, Alyssa M Bagadion, Richa Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2026
Evolution of AR and non-AR alterations in circulating tumor DNA of metastatic prostate cancer patients treated in the phase 3 Alliance A031201 trialJosé C Valentín López, Chenxi Yu, Todd P Knutson, et al.
Pageof 25